FYERS
Home
/
Stocks
/
Results
/
Alembic Pharmaceuticals Results

Alembic Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
9%6%9%10%
-1%-10%25%15%
2%1%4%-10%
18%11%12%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
APLLTD
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
850₹16596 Cr23.938.8152.7₹675 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
————————————————
₹39 Cr₹39 Cr₹39 Cr₹39 Cr₹39 Cr₹39 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹38 Cr₹11 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹27 Cr
₹5636 Cr₹5152 Cr₹4779 Cr₹4331 Cr₹5198 Cr₹5028 Cr₹3182 Cr₹2681 Cr₹2182 Cr₹1865 Cr₹1560 Cr₹847 Cr₹638 Cr₹465 Cr₹357 Cr₹259 Cr
₹5636 Cr₹5152 Cr₹4779 Cr₹4331 Cr₹5198 Cr₹5028 Cr₹3182 Cr₹2681 Cr₹2182 Cr₹1865 Cr₹1560 Cr₹847 Cr₹638 Cr₹465 Cr₹357 Cr₹259 Cr
₹5675 Cr₹5191 Cr₹4818 Cr₹4370 Cr₹5238 Cr₹5067 Cr₹3219 Cr₹2719 Cr₹2220 Cr₹1902 Cr₹1597 Cr₹885 Cr₹676 Cr₹503 Cr₹395 Cr₹297 Cr
-₹6 Cr-₹1 Cr₹0₹0₹0₹0-₹29 Cr-₹79 L₹31 L₹11 L₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹19 Cr₹42 Cr₹60 Cr₹76 Cr₹90 Cr
₹122 Cr₹0₹0₹0₹0₹200 Cr₹887 Cr₹499 Cr₹500 Cr₹0₹0₹0₹10 Cr₹11 Cr₹19 Cr₹39 Cr
-₹270 Cr-₹166 Cr-₹170 Cr-₹123 Cr-₹6 Cr₹4 Cr₹12 Cr₹19 Cr₹35 Cr₹37 Cr₹43 Cr₹31 Cr₹23 Cr₹14 Cr₹10 Cr₹5 Cr
₹225 Cr₹47 Cr₹63 Cr₹69 Cr₹72 Cr₹72 Cr₹73 Cr₹0₹0₹0₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹12 Cr₹12 Cr
₹153 Cr₹124 Cr₹110 Cr₹106 Cr₹96 Cr₹86 Cr₹75 Cr₹52 Cr₹41 Cr₹57 Cr₹28 Cr₹9 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr
₹230 Cr₹5 Cr₹3 Cr₹52 Cr₹162 Cr₹361 Cr₹1047 Cr₹570 Cr₹576 Cr₹94 Cr₹84 Cr₹72 Cr₹94 Cr₹103 Cr₹122 Cr₹151 Cr
————————————————
₹835 Cr₹880 Cr₹736 Cr₹680 Cr₹706 Cr₹669 Cr₹626 Cr₹644 Cr₹759 Cr₹501 Cr₹566 Cr₹325 Cr₹288 Cr₹240 Cr₹209 Cr₹139 Cr
₹394 Cr₹232 Cr₹224 Cr₹251 Cr₹517 Cr₹558 Cr₹227 Cr₹380 Cr₹143 Cr₹81 Cr₹52 Cr₹45 Cr₹61 Cr₹69 Cr₹152 Cr₹85 Cr
₹1219 Cr₹1196 Cr₹430 Cr₹636 Cr₹430 Cr₹2 L₹861 Cr₹429 Cr₹208 Cr₹89 Cr₹114 Cr₹220 Cr₹25 Cr₹70 Cr₹138 Cr₹146 Cr
₹239 Cr₹207 Cr₹131 Cr₹74 Cr₹178 Cr₹307 Cr₹241 Cr₹210 Cr₹157 Cr₹143 Cr₹213 Cr₹319 Cr₹228 Cr₹149 Cr₹84 Cr₹44 Cr
₹2687 Cr₹2514 Cr₹1520 Cr₹1641 Cr₹1831 Cr₹1533 Cr₹1954 Cr₹1664 Cr₹1267 Cr₹814 Cr₹944 Cr₹908 Cr₹603 Cr₹529 Cr₹583 Cr₹413 Cr
₹8586 Cr₹7709 Cr₹6341 Cr₹6064 Cr₹7230 Cr₹6961 Cr₹6192 Cr₹4952 Cr₹4064 Cr₹2811 Cr₹2626 Cr₹1865 Cr₹1372 Cr₹1135 Cr₹1100 Cr₹861 Cr
₹160 Cr₹69 Cr₹55 Cr₹109 Cr₹63 Cr₹100 Cr₹118 Cr₹104 Cr₹94 Cr₹82 Cr₹109 Cr₹105 Cr₹57 Cr₹0₹0₹0
₹1361 Cr₹1196 Cr₹430 Cr₹636 Cr₹630 Cr₹500 Cr₹1747 Cr₹1128 Cr₹708 Cr₹89 Cr₹114 Cr₹263 Cr₹109 Cr₹187 Cr₹353 Cr₹328 Cr
————————————————
₹4897 Cr₹4117 Cr₹3875 Cr₹3468 Cr₹2840 Cr₹2545 Cr₹2132 Cr₹1523 Cr₹1242 Cr₹950 Cr₹1094 Cr₹861 Cr₹665 Cr₹572 Cr₹463 Cr₹434 Cr
₹1816 Cr₹1594 Cr₹1329 Cr₹1069 Cr₹1042 Cr₹757 Cr₹581 Cr₹364 Cr₹249 Cr₹151 Cr₹386 Cr₹314 Cr₹268 Cr₹228 Cr₹195 Cr₹162 Cr
₹3081 Cr₹2524 Cr₹2547 Cr₹2398 Cr₹1798 Cr₹1788 Cr₹1552 Cr₹1158 Cr₹993 Cr₹799 Cr₹708 Cr₹547 Cr₹397 Cr₹344 Cr₹268 Cr₹272 Cr
₹634 Cr₹837 Cr₹524 Cr₹601 Cr₹2206 Cr₹1944 Cr₹1574 Cr₹1341 Cr₹911 Cr₹369 Cr₹93 Cr₹83 Cr₹21 Cr₹32 Cr₹58 Cr₹27 Cr
₹141 Cr₹127 Cr₹93 Cr₹96 Cr₹118 Cr₹49 Cr₹18 Cr₹49 Cr₹42 Cr₹50 Cr₹53 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹141 Cr₹127 Cr₹93 Cr₹96 Cr₹118 Cr₹49 Cr₹18 Cr₹49 Cr₹42 Cr₹50 Cr₹53 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹15 Cr₹31 Cr₹33 Cr₹54 Cr₹35 Cr₹37 Cr₹111 Cr₹62 Cr₹71 Cr₹71 Cr₹30 Cr₹118 Cr₹95 Cr₹36 Cr₹35 Cr₹7 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹33 Cr₹0₹0₹0₹0₹0
₹3920 Cr₹3519 Cr₹3197 Cr₹3150 Cr₹4255 Cr₹4057 Cr₹3526 Cr₹2820 Cr₹2116 Cr₹1317 Cr₹917 Cr₹750 Cr₹516 Cr₹416 Cr₹364 Cr₹308 Cr
————————————————
₹0₹0₹0₹0₹0₹187 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹2511 Cr₹2288 Cr₹1644 Cr₹1475 Cr₹1610 Cr₹1486 Cr₹1188 Cr₹967 Cr₹734 Cr₹633 Cr₹570 Cr₹383 Cr₹311 Cr₹267 Cr₹259 Cr₹219 Cr
₹1466 Cr₹1400 Cr₹1025 Cr₹1046 Cr₹807 Cr₹349 Cr₹865 Cr₹489 Cr₹526 Cr₹339 Cr₹350 Cr₹361 Cr₹273 Cr₹233 Cr₹199 Cr₹202 Cr
₹203 Cr₹90 Cr₹127 Cr₹82 Cr₹69 Cr₹106 Cr₹81 Cr₹206 Cr₹90 Cr₹160 Cr₹451 Cr₹27 Cr₹24 Cr₹16 Cr₹47 Cr₹6 Cr
₹81 Cr₹69 Cr₹60 Cr₹55 Cr₹52 Cr₹79 Cr₹28 Cr₹18 Cr₹27 Cr₹8 Cr₹7 Cr₹0₹0₹0₹0₹0
₹375 Cr₹343 Cr₹289 Cr₹255 Cr₹437 Cr₹698 Cr₹504 Cr₹452 Cr₹570 Cr₹355 Cr₹330 Cr₹344 Cr₹248 Cr₹203 Cr₹231 Cr₹125 Cr
₹4636 Cr₹4190 Cr₹3144 Cr₹2914 Cr₹2975 Cr₹2904 Cr₹2665 Cr₹2132 Cr₹1948 Cr₹1494 Cr₹1708 Cr₹1115 Cr₹857 Cr₹719 Cr₹736 Cr₹553 Cr
₹1949 Cr₹1675 Cr₹1624 Cr₹1273 Cr₹1144 Cr₹1371 Cr₹711 Cr₹468 Cr₹680 Cr₹680 Cr₹764 Cr₹207 Cr₹254 Cr₹191 Cr₹153 Cr₹139 Cr
₹8586 Cr₹7709 Cr₹6341 Cr₹6064 Cr₹7230 Cr₹6961 Cr₹6192 Cr₹4952 Cr₹4064 Cr₹2811 Cr₹2626 Cr₹1865 Cr₹1372 Cr₹1135 Cr₹1100 Cr₹861 Cr
₹289₹264₹245₹222₹266₹258₹171₹144₹118₹101₹85₹47₹36₹27₹21₹49
₹289₹264₹245₹222₹266₹258₹171₹144₹118₹101₹85₹47₹36₹27₹21₹49

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
₹694 Cr₹707 Cr₹632 Cr₹355 Cr₹625 Cr₹1368 Cr₹1000 Cr₹749 Cr₹541 Cr₹529 Cr₹936 Cr₹359 Cr₹311 Cr₹206 Cr₹161 Cr₹107 Cr
₹449 Cr₹374 Cr₹287 Cr₹488 Cr₹418 Cr₹102 Cr₹278 Cr₹118 Cr₹87 Cr₹83 Cr₹70 Cr₹45 Cr₹70 Cr₹53 Cr₹75 Cr₹55 Cr
-₹257 Cr-₹921 Cr-₹96 Cr-₹58 Cr-₹367 Cr₹238 Cr-₹593 Cr₹112 Cr-₹181 Cr-₹166 Cr₹139 Cr-₹163 Cr-₹72 Cr₹44 Cr-₹62 Cr-₹49 Cr
₹886 Cr₹159 Cr₹823 Cr₹785 Cr₹676 Cr₹1709 Cr₹685 Cr₹978 Cr₹448 Cr₹447 Cr₹1145 Cr₹241 Cr₹309 Cr₹304 Cr₹174 Cr₹113 Cr
₹783 Cr₹88 Cr₹803 Cr₹724 Cr₹552 Cr₹1463 Cr₹449 Cr₹812 Cr₹312 Cr₹329 Cr₹948 Cr₹172 Cr₹240 Cr₹265 Cr₹142 Cr₹95 Cr
-₹506 Cr-₹568 Cr-₹321 Cr-₹448 Cr-₹372 Cr-₹839 Cr-₹732 Cr-₹756 Cr-₹884 Cr-₹486 Cr-₹307 Cr-₹256 Cr-₹81 Cr-₹67 Cr-₹56 Cr-₹57 Cr
-₹164 Cr₹444 Cr-₹438 Cr-₹262 Cr-₹217 Cr-₹597 Cr₹155 Cr₹59 Cr₹503 Cr-₹129 Cr-₹224 Cr₹87 Cr-₹151 Cr-₹229 Cr-₹45 Cr-₹47 Cr
₹113 Cr-₹37 Cr₹45 Cr₹14 Cr-₹37 Cr₹27 Cr-₹128 Cr₹115 Cr-₹69 Cr-₹286 Cr₹417 Cr₹3 Cr₹8 Cr-₹31 Cr₹41 Cr-₹9 Cr
₹83 Cr₹120 Cr₹75 Cr₹61 Cr₹98 Cr₹72 Cr₹199 Cr₹84 Cr₹153 Cr₹439 Cr₹23 Cr₹24 Cr₹16 Cr₹47 Cr₹6 Cr₹15 Cr
₹0₹0₹0₹0₹0-₹93 L₹41 L-₹7 L₹0₹0₹0₹0₹0₹0₹0₹0
₹196 Cr₹83 Cr₹120 Cr₹75 Cr₹61 Cr₹98 Cr₹72 Cr₹199 Cr₹84 Cr₹153 Cr₹439 Cr₹27 Cr₹24 Cr₹16 Cr₹47 Cr₹6 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)840.00
Volume (₹)3.54 L
High (₹)858.40
Upper Circuit1,013.25
Low (₹)834.95
Lower Circuit675.55
Prev Close844.40
52W High (₹)998.00
Price850.00
52W Low (₹)635.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)16595.80 Cr
Div. Yield (%)1.42
PE Ratio23.93
Debt to Equity0.24
Price to Book2.29
Book Value288.72
EPS (TTM)35.28
Face Value2.00
ROE (%)12.35

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
APLLTDNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
850+4.25 (0.50%)
834.95
867.85
16,596Cr

Alembic Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹346.79Cr; with other income of ₹14.93Cr, profit before interest and tax came to ₹249.08Cr. Interest expense was ₹27.61Cr; PBT before exceptional items stood at ₹221.47Cr. Cost mix (full year): raw materials ₹2256.26Cr; employee cost ₹1731.93Cr; depreciation ₹97.71Cr; other expenses ₹1817.91Cr. Basis: consolidated annual results.

Alembic Pharmaceuticals Ltd Quaterly Results Key Takeaways

Alembic Pharmaceuticals Ltd reported ₹2149.77Cr total income from operations in Jun 2026, softer than ₹1847.72Cr in Mar 2026 but higher than ₹1710.72Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹346.79Cr; with other income of ₹14.93Cr, profit before interest and tax came to ₹249.08Cr. Interest expense was ₹27.61Cr, taking profit before tax to ₹221.47Cr. After tax of ₹49.5Cr, profit after tax stood at ₹171.97Cr (vs ₹200.42Cr in Mar 2026 and ₹154.08Cr in Jun 2025).